Skip to main content
. 2022 Feb 18;14(4):1054. doi: 10.3390/cancers14041054

Figure 1.

Figure 1

This figure shows current position of immunotherapy for advanced gastric cancer. Abbreviations: CPS: PD-L1 combined positive score; T-DXd: trastuzumab deruxtecan.